Back
American Software 10K Form
Buy
55
AMSWA
American Software
Last Price:
9.99
Seasonality Move:
0.79%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-03-01 | 10Q | AMSWA/American Software Quarterly |
2023-12-11 | 10Q | AMSWA/American Software Quarterly |
2023-09-01 | 10Q | AMSWA/American Software Quarterly |
2023-03-03 | 10Q | AMSWA/American Software Quarterly |
2022-12-02 | 10Q | AMSWA/American Software Quarterly |
2022-09-02 | 10Q | AMSWA/American Software Quarterly |
Receive AMSWA News And Ratings
See the #1 stock for the next 7 days that we like better than AMSWA
AMSWA Financial Statistics
Sales & Book Value
Annual Sales: | $123.66M |
---|---|
Cash Flow: | $1.37M |
Price / Cash Flow: | 18.04 |
Annual Sales: | $3.95 |
Price / Book: | 2.53 |
Profitability
EPS (TTM): | 0.35000 |
---|---|
Net Income (TTM): | $12.23M |
Gross Margin: | $74.29M |
Return on Equity: | 9% |
Return on Assets: | 6.52% |
American Software Earnings Forecast
Key American Software Financial Ratios
- The Gross Profit Margin over the past 40 years for AMSWA is 60.08%.
- The Selling, General & Administrative Expenses for AMSWA have been equal to 37.09% of Gross Profit Margin.
- The Research & Development expenses have been 14.37% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of AMSWA is 8.43% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 20 years.
American Software Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Software |
Sector: | Information Technology |
Current Symbol: | AMSWA |
CUSIP: | 029683 |
Website: | amsoftware.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 2.29 |
Quick Ratio: | 2.15 |
Price-to-Earnings
Trailing P/E Ratio: | 32.19 |
---|---|
Forward P/E Ratio: | 22.94 |
AMSWA Technical Analysis vs Fundamental Analysis
Buy
55
American Software (AMSWA)
is a Buy
Is American Software a Buy or a Sell?
-
American Software stock is rated a Buy
The current American Software [AMSWA] share price is $9.98. The Score for AMSWA is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.